RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Equar Taka to Pulmonary Alveoli

Back to Details
This is a "connection" page, showing publications Equar Taka has written about Pulmonary Alveoli.
Equar Taka
Connection Strength
0.415
Pulmonary Alveoli
  1. Taka E, Errahali YJ, Abonyo BO, Bauer DM, Heiman AS. Post-transcriptional silencing of CCR3 downregulates IL-4 stimulated release of eotaxin-3 (CCL26) and other CCR3 ligands in alveolar type II cells. Cytokine. 2008 Dec; 44(3):342-51.
    View in: PubMed
    Score: 0.331
  2. Errahali YJ, Taka E, Abonyo BO, Heiman AS. CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy. J Interferon Cytokine Res. 2009 Apr; 29(4):227-39.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support